Literature DB >> 11087156

Interleukin-2 and interferon-gamma double knockout mice reject heterotopic cardiac allografts.

M S Zand1, Y Li, W Hancock, X C Li, P Roy-Chaudhury, X X Zheng, T B Strom.   

Abstract

BACKGROUND: Several studies suggest that MHC-mismatched allografts reject with a Th1 or Th2 immune response, but these models all have low-level expression of the Th1 cytokines interleukin (IL)-2 and interferon-gamma (IFN-gamma).
METHODS: We interbred mice with single targeted gene disruptions for IL-2 and IFN-gamma to establish IL-2 + IFN-gamma double knockout (DKO) mice. Heterotopic cardiac allografts from DBA/2j (H2d) donors were transplanted WT, IL-2 knockout (KO), IFN-gamma KO, and DKO recipients (C57BL/6x129; H2b). Cytokine transcripts from allografts and DKO splenocytes were analyzed by reverse transcription polymerase chain reaction.
RESULTS: DKO mice had a cytokine profile and IgG1/ IgG2a isotype ratio characteristic of Th2 deviation. DKO recipients rejected heterotopic cardiac allografts faster than IL-2 KO mice, but significantly slower than WT and IFN-gamma KO mice (P<0.01). Analysis of the rejecting DKO recipients showed intragraft Th2 cytokine expression.
CONCLUSION: The combined absence of IL-2 and IFN-gamma in the setting of Th2 deviation does not prevent allograft rejection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11087156     DOI: 10.1097/00007890-200011150-00019

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  2 in total

1.  Gamma c cytokines condition the progressive differentiation of CD4+ T cells.

Authors:  Guillemette X Masse; Erwan Corcuff; Hélène Strick-Marchand; Delphine Guy-Grand; Anna Tafuri-Bladt; Matthew L Albert; Olivier Lantz; James P Di Santo
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-12       Impact factor: 11.205

2.  Deletion of DOCK2, a regulator of the actin cytoskeleton in lymphocytes, suppresses cardiac allograft rejection.

Authors:  Hongsi Jiang; Fan Pan; Laurie M Erickson; Mei-Shiang Jang; Terukazu Sanui; Yuya Kunisaki; Takehiko Sasazuki; Masakazu Kobayashi; Yoshinori Fukui
Journal:  J Exp Med       Date:  2005-10-17       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.